Elanco Animal Health Reports Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Elanco Animal Health (ELAN) Tops Q4 EPS by 88c, Offers Guidance
February 24, 2022 6:34 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $1.05, $0.88 better than the analyst estimate of $0.17. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.1 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2022 EPS of $0.33-$0.38, versus the... More
